Novartis stock: third-quarter results on October 27 ahead of Xetra open
Published on 10/19/2026 at 07:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor calendar and pre-market
- Novartis has scheduled its third-quarter results for October 27, 2026.
- The Remibrutinib in MS investor call is set for October 23, 2026.
- Novartis stock trades pre-market at EUR 134.86 at 7:48 a.m. CEST at Lang & Schwarz on October 19, 2026.
Novartis has scheduled its third-quarter results for October 27, 2026, according to the company’s investor calendar. At Lang & Schwarz, Novartis stock trades pre-market at EUR 134.86 at 7:48 a.m. CEST on October 19, 2026.
Upcoming investor dates
Novartis has also listed a Remibrutinib in MS investor call for October 23, 2026, at 12:30 a.m. CEST, followed by the third-quarter results webcast on October 27, 2026, at 1:00 p.m. CET, according to the company’s investor relations page.
Pre-market indication
The pre-market quote is provided by Lang & Schwarz for October 19, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Novartis stock.
Novartis and the market
Novartis develops medicines for patients and reports to investors through its pharmaceutical business. The company’s investor calendar places both the Remibrutinib call and quarterly results in the week beginning October 19, 2026. Market context: Market report SMI.
